Sakamoto Yuka | Drug Safety Research Center Developmental Research Laboratories Daiichi Pharmaceutical Co. Ltd.
スポンサーリンク
概要
- SAKAMOTO Yukaの詳細を見る
- 同名の論文著者
- Drug Safety Research Center Developmental Research Laboratories Daiichi Pharmaceutical Co. Ltd.の論文著者
関連著者
-
Nomura Mamoru
Drug Safety Research Center Developmental Research Laboratories Daiichi Pharmaceutical Co. Ltd.
-
YAMADA Masao
Drug Safety Research Center, Developmental Research Laboratories, Daiichi Pharmaceutical Co., Ltd.
-
SAKAMOTO Yuka
Drug Safety Research Center, Developmental Research Laboratories, Daiichi Pharmaceutical Co., Ltd.
-
Sakamoto Yuka
Drug Safety Research Center Developmental Research Laboratories Daiichi Pharmaceutical Co. Ltd.
-
Yamada Masao
Drug Safety Research Center Developmental Research Laboratories Daiichi Pharmaceutical Co. Ltd.
-
Yamada Masao
Drug Safety Research Center Research Institute Daiichi Seiyaku Co. Ltd.
-
Nomura Mamoru
Drug Safety Research Laboratory Daiichi Pharmaceutical Co. Ltd.
-
Kikuchi Noriko
Drug Safety Research Center Developmental Research Laboratories Daiichi Pharmaceutical Co. Ltd.
-
Nomura Mamoru
Drug Safety Research Center Daiichi Pharmaceutical Co. Ltd.
-
NOMURA Mamoru
Research institute, Daiichi Seiyaku Co., Ltd.
-
Sato Hiroshi
Drug Safety Research Laboratory, Daiichi Pharmaceutical Co., Ltd.
-
YAMADA Masao
Research Institute, DAIICHI Pharmaceutical Co. Ltd.
-
SAKAMOTO Yuka
Research Institute, DAIICHI Pharmaceutical Co. Ltd.
-
OHNO Hiroshi
Research Institute, DAIICHI Pharmaceutical Co. Ltd.
-
Nomura Mamoru
Research Institute Daiichi Seiyaku Co. Ltd.
-
Nomura Mamoru
Drug Safety Research Cehter Developmental Research Lab. Daiichi Pharmaceutical Co. Ltd.
-
Ohno Hiroshi
Research Institute Daiichi Pharmaceutical Co. Ltd.
-
Ohno Hiroshi
Research & Development Department Biofermin Pharmaceutical Co. Ltd.
-
SATO Hiroshi
Drug Safety Research Center, Developmental Research Laboratories, Daiichi Pharmaceutical Co., Ltd.
著作論文
- 229 EDEMA INDUCTION BY ARGININE SOLUTION IN RATS
- A-2 Electroretinographic changes induced by the concomitant administration of new quinolones and a nonsteroidal antiinflammatory drug.